Overview

• Before Judge Ernesto Kreplak, the HLB Pharma and Laboratorios Ramallo owner declared for six hours, rejected responsibility, and accused former collaborator Andrés Quinteros of deliberate contamination.
• He said he is bankrupt, faulted the regulator ANMAT for failing to warn earlier, and alleged a media and political operation against his businesses.
• Investigators are concentrating on late‑2024 batches, particularly lot 31.202, with ANLIS‑Malbrán reporting Klebsiella and Ralstonia bacteria in analyzed ampoules.
• Judicial actions include at least ten detentions, with 96 patient deaths reported in the case and 134 clinical records under review as broader causality findings remain pending.
• Two men listed as Ramallo’s president and vice president told the court they merely lent their names, raising fresh questions about corporate governance and traceability.